Sanjay Bagaria, MD
Dr. Sanjay Bagaria is a surgical oncologist and Division Chair for Surgical Oncology at the Mayo Clinic in Jacksonville, Florida. His clinical interest lies in individualizing cancer care based on the tumor and patient characteristics.[1] His clinical focus includes the treatment of malignant peritoneal mesothelioma using a complex surgical procedure that combines cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC).
Dr. Bagaria also performs sentinel node biopsies and treats patients for sarcoma, melanoma, and breast cancer, as well as many other challenging conditions.
Education and Career
Dr. Bagaria completed his undergraduate education at the University of Michigan and earned his medical degree from the New Jersey Medical School at Rutgers University. He pursued a research fellowship in Genetic Medicine at Weill Cornell Medical College and then completed an internship and residency in General Surgery at Weill Cornell Medical College/New York Presbyterian Hospital. He also fulfilled a fellowship in Surgical Oncology at the John Wayne Cancer Institute of St. John’s Health Center.[1]
Professional Memberships and Activities
Dr. Bagaria is actively involved in several professional medical organizations, including:[1]
- Cancer Surgery Standards Program, American College of Surgeons
- High Definition Therapeutics Team Lead, Mayo Clinic Center for Individualized Medicine
- Diversity and Inclusion Committee, Society of Surgical Oncology
- Member, Center for Individualized Medicine, Steering Committee
- Associate Director, Mayo Clinic Center for Individualized Medicine
- Annual Meeting Reimagination Task Force, Society of Surgical Oncology
- Member, Transatlantic Australasian Retroperitoneal Sarcoma Working Group
Research
Dr. Bagaria’s research is focused on transforming healthcare using digital technologies. He also uses next-generation sequencing technology to study the tumor and tumor microenvironment of sarcoma, peritoneal surface malignancies, and melanoma. The long-term goal of Dr. Bagaria’s research is to develop locoregional therapies that can prevent and eradicate these tumors.[1]
Dr. Bagaria’s research is published in high-impact scientific journals and is an invited speaker for national and international organizations.
Some of his recent publications include:[2]
A Unicorn Disease: The Large Duct Variant of Invasive Ductal Adenocarcinoma of the Pancreas. Ahmed Elhariri, Jason S Starr, Sanjay Bagaria, Nguyen Tran, Hani Babiker>; Cureus. 2023 Jul 1
How Well Does Non-mass Enhancement Correlate With DCIS/Invasive Cancer? Kai Huang, Maria Dufresne, Mizba Baksh, Samuel Nussbaum, Ali Abbaszadeh Kasbi, Ashary Mohammed, Pooja Advani, Andrey Morozov, Sanjay Bagaria, Sarah McLaughlin, Emmanue…>; The American Surgeon. 2023 Dec 1
Human intravital microscopy in the study of sarcomas: an early trial of feasibility. Emmanuel M Gabriel, Kyle Popp, Sanjay P Bagaria, Sukniam, K., Sukniam, K., Kulkaew Sukniam>; Frontiers in Oncology. 2023 Jan 1
